Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic Determinants of ACEI Prodrug Activation
NCT03051282Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Apr 2017
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of enalapril in hypertension (HTN) (2 arms), sponsored by University of Michigan. Primary endpoint: Area Under the Curve of enalaprilat plasma concentrations at 72 hours. Started Apr 2017; status: completed.
02
Drugs
enalapril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03051282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03051282.